Oncternal Therapeutics, Inc. (ONCT): Price and Financial Metrics
ONCT Price/Volume Stats
| Current price | $1.14 | 52-week high | $13.14 |
| Prev. close | $1.08 | 52-week low | $1.03 |
| Day low | $1.06 | Volume | 26,200 |
| Day high | $1.14 | Avg. volume | 34,747 |
| 50-day MA | $1.39 | Dividend yield | N/A |
| 200-day MA | $6.13 | Market Cap | 3.37M |
ONCT Stock Price Chart Interactive Chart >
Oncternal Therapeutics, Inc. (ONCT) Company Bio
Oncternal Therapeutics (formerly GTx, Inc.), a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of breast and prostate cancer, and other serious medical conditions. The company was founded in 1997 and is based in Memphis, Tennessee.
ONCT Price Returns
| 1-mo | -32.98% |
| 3-mo | -76.96% |
| 6-mo | -87.62% |
| 1-year | -82.46% |
| 3-year | -98.07% |
| 5-year | -99.04% |
| YTD | -89.37% |
| 2023 | -46.38% |
| 2022 | -55.95% |
| 2021 | -53.67% |
| 2020 | 24.05% |
| 2019 | -27.66% |
Loading social stream, please wait...